Paget Disease of the Vulva

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-06-16
Clinical Trial Update: Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease [Phase 2]
A phase 2 clinical trial evaluating trastuzumab for HER2-positive Paget's disease of the vulva has been withdrawn.